期刊文献+

fas基因修饰食管癌细胞的体外抑瘤效应 被引量:4

IN VITRO ANTI-TUMOR EFFECTS OF fas GENE ON OESOPHAGEAL CANCER CELLS
下载PDF
导出
摘要 为研究fas基因转导对食管癌细胞的体外抑制作用 ,构建fas基因真核表达载体fas pBK并将其转导入食管癌细胞EC10 9。Westernblot结果证实fas基因转导株Fas EC10 9表达高水平的Fas蛋白 ;细胞生长曲线和软琼脂集落形成实验结果显示 ,与对照细胞相比 ,Fas EC10 9的群体倍增时间延长 ,克隆形成能力降低。MTT比色法表明Fas EC10 9对CDDP、VCR、5 FU的敏感性明显增加。本研究结果提示 ,转导fas基因能有效抑制体外培养的食管癌细胞的生长 。 To evaluate the inhibitory effects of fas gene transduction on oesophageal cancer cells in vitro, the eukaryotic expression vector fas pBK was constructed and transfected into oesophageal carcinoma cells EC109. Western blot results showed high expression of Fas protein in gene transfected cells Fas EC109. Cell growth curve and plating efficiency test revealed that Fas EC109 had longer population doubling time and lower plating efficiency compared with control cells. Results of MTT assay showed increased sensitivity of Fas EC109 cells to CDDP, VCR and 5 FU. All these data suggested that transgenic expression of fas gene could effectively inhibit the proliferation and increase the drug sensitivity of oesophageal carcinoma cells in vitro.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2001年第11期801-803,共3页 Medical Journal of Chinese People's Liberation Army
关键词 食管肿瘤 FAS基因 基因治疗 细胞凋亡 体外抑瘤 oesophagus neoplasms gene, fas gene therapy apoptosis
  • 相关文献

参考文献6

二级参考文献5

共引文献29

同被引文献41

  • 1杨迪生,徐玉生,叶招明,苗旭东.TRAIL基因与顺铂协同诱导横纹肌肉瘤细胞凋亡的实验研究[J].中华骨科杂志,2004,24(7):422-426. 被引量:1
  • 2钱频,戢福云,钱桂生,黄桂君,陈琰,郭芮琳.顺铂诱导人小细胞肺癌多药耐药细胞系NCI-H446/CDDP的建立及其生物学特征分析[J].解放军医学杂志,2004,29(12):1052-1054. 被引量:11
  • 3Ashkenazi A, Pai RC, Fong S, et al. Safety and antitumor activity of recombinant soluble Apo2 ligand[J]. Clin Invest, 1999, 104(2):155-162.
  • 4Walczak H, Miller RE, Ariail K, et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo[J]. Nat Med, 1999, 5(2): 157-163.
  • 5Mizutania Y, Nakanishia H, Yoshidab O, et al. Potentiation of the sensitivity of renal cell carcinoma cells to TRAIL-mediated apoptosis by subtoxic concentrations of 5-fluorouracil[J]. Eur J Cancer, 2002, 38(1):167-176.
  • 6Cuello M, Ettenberg SA, Nan MM, et al. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells[J]. Gynecol Oncol, 2001, 81(3):380-390.
  • 7Hemandez A, Wang Q, Sehwartz SA, et al. Sensitization of human colon cancer to trail-mediated apoptosis[J]. J Gastrointest Surg, 2001, 5(1):56-65.
  • 8Zhang XD, Franco A, Nyerg K, et al. Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma[J]. Cancer Res, 1999, 59(11): 2747-2758.
  • 9Griffith TS, Chin WA, Jackson GC, et al. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells[J]. J Immunol, 1998, 161(6):2833-2840.
  • 10Vignati S, Codegoni A, Polato F, et al. Trail activity in human ovarian cancer cells:potentiation of the action of cytotoxic drugs[J]. Eur J Cancer, 2002, 38(1):177-183.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部